Dieterich's disease

From WikiMD's WELLNESSPEDIA

Dieterich's disease, also known as avascular necrosis of the metatarsal head, is a rare condition that affects the foot. It is characterized by the loss of blood supply to the metatarsal head, leading to the death of bone tissue. This condition is named after the German surgeon who first described it.

Pathophysiology[edit]

Dieterich's disease primarily affects the second or third metatarsal head. The lack of blood supply causes the bone tissue to die, which can lead to the collapse of the metatarsal head and subsequent arthritis. The exact cause of the disrupted blood supply is not well understood, but it may be related to trauma, excessive use, or underlying medical conditions.

Symptoms[edit]

The symptoms of Dieterich's disease include:

  • Pain in the affected metatarsal head, especially during weight-bearing activities
  • Swelling and tenderness in the forefoot
  • Limited range of motion in the affected toe
  • Development of a limp due to pain

Diagnosis[edit]

Diagnosis of Dieterich's disease is typically made through a combination of clinical examination and imaging studies. X-rays can reveal changes in the bone structure, while MRI scans can provide detailed images of the bone and surrounding tissues, showing areas of necrosis.

Treatment[edit]

Treatment options for Dieterich's disease vary depending on the severity of the condition. They may include:

  • Rest and avoidance of weight-bearing activities
  • Use of orthotic devices to offload pressure from the affected metatarsal head
  • Pain management with medications
  • Physical therapy to maintain range of motion and strength
  • Surgical intervention in severe cases, such as core decompression or osteotomy

Prognosis[edit]

The prognosis for Dieterich's disease varies. Early diagnosis and treatment can improve outcomes and prevent progression to more severe stages. However, in advanced cases, the condition can lead to chronic pain and disability.

Related Pages[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.